Skip to main content

Dexcom Expands G6 Access to Indigenous People in Canada

Published: 1/23/23 11:52 am
By Andrew Briskin

A health benefits program for uninsured individuals expanded eligibility for coverage of the Dexcom G6 continuous glucose monitor (CGM) to all people with type 1 diabetes in Canada, regardless of age.

Dexcom announced on Jan. 17 that Canada’s Non-Insured Health Benefits (NIHB) Program will provide coverage for Dexcom’s G6 continuous glucose monitor (CGM) to all Canadians with type 1 diabetes who are enrolled in the program.  

The NIHB Program provides coverage for a wide variety of medications and other healthcare services for First Nations and Inuit communities across Canada. Previously, the program only covered Dexcom G6 for individuals ages 2-19 on intensive insulin therapy. With the expanded coverage, however, all people in the program with type 1 diabetes are covered for a CGM.

Dexcom G6, a wearable glucose monitor, measures glucose levels every five minutes and sends these levels to a connected smartphone or wireless reader. Stored and displayed in a mobile app, glucose data can easily be viewed and shared between G6 users and their healthcare providers.

Additionally, using a CGM has been shown to help people with diabetes improve their glucose management and significantly reduce the risk for long-term complications like heart and kidney disease. According to the American Diabetes Association’s 2023 Standards of Care, CGM is now recommended for all people with type 1 diabetes and those with type 2 on insulin therapy.

Expanded eligibility under the NIHB program could significantly improve access to CGM for First Nations and Inuit communities across Canada – vital given the impact that diabetes continues to have in these communities.

“Indigenous, First Nations and Inuit communities are disproportionately impacted by diabetes beyond childhood and adolescence, making this announcement a key step forward to ensuring better glucose control, improved health outcomes and reduced risk of developing diabetes-related complications,” said Dr. Jeff Winterstein, an Edmonton-based internal medicine specialist who works with many NIHB patients with diabetes, in a press release from Dexcom.

“CGM can help to bridge the distance between remote communities and care providers,” Winterstein said. “Dexcom CLARITY [mobile app] software allows me to remotely see a patient’s glucose data and trends over time so I can make the appropriate adjustments and treatment decisions.”

For those eligible to receive healthcare resources through the NIHB program, the expanded coverage could improve care for thousands with type 1 diabetes. For more about NIHB, eligibility, and enrollment, see the NIHB website.

What do you think?

About the authors

Andrew Briskin joined the diaTribe Foundation in 2021 after graduating from the University of Pennsylvania with a degree in Health and Societies . Briskin is an Editor for diaTribe Learn.... Read the full bio »